Aramark (ARMK) filings document a Delaware operating company with NYSE-listed common stock and a business centered on food, facilities management, hospitality, and support services. Its 8-K reports include operating results, material definitive agreements, annual meeting voting results, and compensation matters involving restricted stock units and executive equity awards.
Proxy materials disclose board elections, auditor ratification, executive compensation, equity awards, shareholder voting matters, and governance practices. Financing filings also describe amendments to the credit agreement of Aramark Services, Inc., an indirect wholly owned subsidiary, including term-loan refinancing and repricing transactions within the company’s capital structure.
Aramark reported stronger quarterly results for the quarter ended April 3, 2026. Revenue rose to $4.91 billion from $4.28 billion, a 14.7% increase driven by base business growth and new contracts in both U.S. and international operations.
Operating income grew 26.2% to $219.7 million, while net income rose 64.8% to $102.1 million. Diluted EPS increased to $0.38 from $0.23. Cash from operations was a use of $381.9 million, reflecting higher receivables, client payments, and working capital needs alongside continued capital spending and debt refinancing activity.
Aramark reported strong second-quarter fiscal 2026 results with broad-based growth. Revenue rose to $4.91 billion from $4.28 billion, while operating income increased to $219.7 million from $174.2 million. Net income attributable to stockholders grew to $102.0 million, lifting diluted EPS to $0.38 from $0.23.
Adjusted Net Income reached $130.8 million and Adjusted EPS increased to $0.49, both showing double-digit growth. Free Cash Flow for the quarter was $305 million, supported by a 56% increase in net cash provided by operating activities to $400 million. Aramark repaid approximately $55 million of Term Loan B and repurchased about $25 million of stock, and expects its leverage ratio to be under 3.0x by the end of fiscal 2026.
The company updated its fiscal 2026 outlook to target organic revenue growth at the high end of its prior 7%–9% range, while reaffirming Adjusted Operating Income growth of 12%–17%, Adjusted EPS growth of 20%–25%, and leverage under 3x. The Board approved a quarterly dividend of $0.12 per share. Aramark also launched Aramark Nexus™, a new platform focused on the hyperscale AI data center market, and signed a multi-year agreement with a top global hyperscaler, with services beginning this fiscal year.
Aramark reported institutional ownership disclosure by Morgan Stanley reporting units. The Schedule 13G/A shows 13,801,394 shares beneficially owned, representing 5.3% of the class as of 03/31/2026. The filing attributes voting and dispositive powers to shared MS reporting units.
Vanguard Capital Management reported beneficial ownership of 13,799,487 shares of Aramark common stock. The filing states this position represents 5.25% of the class as of 03/31/2026. Vanguard reports sole power to dispose of 13,799,487 shares and sole voting power for 2,006,847 shares. The Schedule 13G lists Vanguard Capital Management's address and CUSIP 03852U106, and is signed on 04/29/2026.
DREILING RICHARD W reported acquisition or exercise transactions in this Form 4 filing.
Aramark director Richard W. Dreiling received an automatic grant of 641 fully vested deferred stock units of common stock, based on a reference price of $42.86 per share. These units represent the director’s election to defer all of his cash retainer into stock-based compensation.
The deferred stock units will be settled in shares of common stock on the first day of the seventh month after his departure from the board. Following this grant, Dreiling directly holds 14,502.162 shares of Aramark common stock.
Creed Greg reported acquisition or exercise transactions in this Form 4 filing.
Aramark director Greg Creed received a grant of 787 fully vested deferred stock units of common stock valued at $42.86 per unit. This represents the director’s election to defer all of his cash retainer into stock-based compensation.
The deferred stock units will be settled in shares of common stock on the first day of the seventh month after the date of his departure from the board. Following this grant, Creed holds 67,354.545 Aramark common shares directly and 12,475 shares indirectly through a trust.
The Vanguard Group reports that it beneficially owns 0 shares of Aramark common stock as filed in Amendment No. 10 to Schedule 13G/A. The filing states Vanguard completed an internal realignment on January 12, 2026 and will report certain subsidiaries separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The filing lists Aramark's principal executive office at 2400 Market St, Philadelphia, PA.
Aramark director Kevin Wills reported an automatic stock-based award tied to dividends. On March 4, 2026, he acquired 47.619 shares of common stock equivalents at a stated price of $0.0000 per share, representing dividend equivalent rights on deferred stock units. After this award, his directly held common stock (and equivalents) totaled 21,903.351 shares. These dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards.
Aramark director Stephen I. Sadove acquired additional common stock through dividend equivalents. On March 4, 2026, he received 258.631 shares of common stock at $0.0000 per share as a grant or award. These dividend equivalent rights accrued on deferred stock units he already held and vest on the same schedules as the underlying awards.
After this transaction, Sadove directly held 102,307.745 shares of Aramark common stock. He also had indirect ownership of 15,000 shares held by a trust, reported as a separate holding.
Aramark director Patricia E. Lopez reported an acquisition of 84.690 shares of common stock-equivalent rights on March 4, 2026. These are dividend equivalent rights credited on deferred stock units in connection with Aramark’s quarterly dividend and carry a price of $0.0000 per share.
After this grant/award acquisition, Lopez’s directly held common stock and related rights total 29,077.206 shares. The dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards, aligning the additional units with her existing equity compensation timeline.